These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1671425)

  • 1. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
    McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
    Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
    Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
    An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
    Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
    J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis.
    Allen ED
    Chest; 1996 Dec; 110(6 Suppl):256S-260S. PubMed ID: 8989161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
    Wewers MD; Casolaro MA; Crystal RG
    Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
    Hubbard RC; Brantly ML; Sellers SE; Mitchell ME; Crystal RG
    Ann Intern Med; 1989 Aug; 111(3):206-12. PubMed ID: 2787611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
    Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
    Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
    Cantin AM; Berthiaume Y; Cloutier D; Martel M
    Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil elastase activity in cystic fibrosis serum.
    Cantin AM; Lafrenaye S; Bégin RO
    Pediatr Pulmonol; 1991; 11(3):249-53. PubMed ID: 1758746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Konstan MW; Hilliard KA; Norvell TM; Berger M
    Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
    Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
    J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
    Meyer KC; Zimmerman J
    J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
    Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
    Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
    J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
    Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
    Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.